These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23169967)

  • 21. Two doses of pandemic influenza A(H1N1) vaccine: tolerability in healthy young children in the Netherlands.
    van't Klooster TM; Kemmeren JM; de Melker HE; Vermeer-de Bondt PE; van der Maas NA
    Hum Vaccin; 2011 Oct; 7(10):1048-54. PubMed ID: 21957494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination strategies to protect children against seasonal and pandemic influenza.
    Rimmelzwaan GF; Bodewes R; Osterhaus AD
    Vaccine; 2011 Oct; 29(43):7551-3. PubMed ID: 21820479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.
    Lu CY; Shao PL; Chang LY; Huang YC; Chiu CH; Hsieh YC; Lin TY; Huang LM
    Vaccine; 2010 Aug; 28(36):5864-70. PubMed ID: 20600484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceptance of vaccination during pregnancy: experience with 2009 influenza A (H1N1) in the Netherlands.
    van Lier A; Steens A; Ferreira JA; van der Maas NA; de Melker HE
    Vaccine; 2012 Apr; 30(18):2892-9. PubMed ID: 22374374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young children.
    Scheifele DW; Ward BJ; Dionne M; Vanderkooi O; Langley JM; Dobson S; Li Y; Law B; Halperin SA;
    Pediatr Infect Dis J; 2011 May; 30(5):402-7. PubMed ID: 21178654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
    Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
    Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
    Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H
    Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China.
    Zhan Y; Yang Z; Li L; Ye D; Wu H; Fu R; Zhao S; Wang Y; Zhou R; Chen R
    Jpn J Infect Dis; 2011; 64(3):190-4. PubMed ID: 21617301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlates of 2009 H1N1 influenza vaccination among day care-aged children, Miami-Dade County.
    Gomez Y; Leguen F; Zhang G; O'Connell E
    Vaccine; 2012 Jun; 30(27):4002-6. PubMed ID: 22542817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uptake of pandemic influenza (H1N1)-2009 vaccines in Brazil, 2010.
    Domingues CM; de Oliveira WK;
    Vaccine; 2012 Jul; 30(32):4744-51. PubMed ID: 22609010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing uptake of influenza A (H1N1) vaccine amongst healthcare workers in a regional pediatric centre: lessons for improving vaccination rates.
    Chen SC; Hawkins G; Aspinall E; Patel N
    Vaccine; 2012 Jan; 30(2):493-7. PubMed ID: 21527302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk perception and information-seeking behaviour during the 2009/10 influenza A(H1N1)pdm09 pandemic in Germany.
    Walter D; Bohmer M; Reiter S; Krause G; Wichmann O
    Euro Surveill; 2012 Mar; 17(13):. PubMed ID: 22490383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers.
    Park SW; Lee JH; Kim ES; Kwak YG; Moon CS; Yeom JS; Lee JH; Lee CS
    Am J Infect Control; 2011 Feb; 39(1):69-71. PubMed ID: 21122948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between intention of novel influenza A (H1N1) vaccination and vaccination coverage rate.
    Kwon Y; Cho HY; Lee YK; Bae GR; Lee SG
    Vaccine; 2010 Dec; 29(2):161-5. PubMed ID: 21055495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.
    Pebody R; Andrews N; Waight P; Malkani R; McCartney C; Ellis J; Miller E
    Vaccine; 2011 Mar; 29(14):2613-8. PubMed ID: 21292008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
    Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C
    Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.
    Rudenko L; van den Bosch H; Kiseleva I; Mironov A; Naikhin A; Larionova N; Bushmenkov D
    Vaccine; 2011 Jul; 29 Suppl 1():A40-4. PubMed ID: 21684428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pandemic influenza A (H1N1) 2009 vaccine: an update.
    Goel MK; Goel M; Khanna P; Mittal K
    Indian J Med Microbiol; 2011; 29(1):13-8. PubMed ID: 21304188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-range study of MF59-adjuvanted versus nonadjuvanted monovalent A/H1N1 pandemic influenza vaccine in six- to less than thirty-six-month-old children.
    Block SL; Ruiz-Palacios GM; Guerrero ML; Beygo J; Sales V; Holmes SJ
    Pediatr Infect Dis J; 2012 Jul; 31(7):e92-8. PubMed ID: 22481427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden.
    Ortqvist A; Berggren I; Insulander M; de Jong B; Svenungsson B
    Clin Infect Dis; 2011 May; 52(10):1203-11. PubMed ID: 21507917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.